FDA Approves COVID-19 Kit For Self-Testing At Home

The USFDA has issued an emergency use authorization (EUA) for a COVID-19 test kit, which can be used at home and provides quick results. COVID-19 diagnostic kits have been previously used for home collection, but the Lucira COVID-19 test kit is the first kit that can be self-administered at home. The kit is a significant step in combating the pandemic and reducing the burden of public transmission of COVID-19. About the kit: Prescription use only. A single-use molecular diagnostic test, with a real-time loop-mediated amplification reaction. Approved for screening COVID-19 suspected patients.

Indicated for individuals of 14 years and above. Authorized for use in point of care (POC), i.e., healthcare settings or under doctor’s observation. Samples should be collected by professionals when used in a POC setting. How does the kit work? Figure 1:  Testing process of kit  (FDA) What next?…